Clinical Trial Update: Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection. [NA]

View source ↗

Summary

This document reports that the continued access study of Adefovir Dipivoxil for chronic hepatitis B has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Adefovir Dipivoxil (Adefovir dipivoxil)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis B | NA | Status: TERMINATED